Quick Answer
HUTCHMED (China) Ltd reported Operating Income of -$39.16 million for fiscal year 2025.
HUTCHMED (China) Ltd Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$39.16M | +10.4% |
| 2024 | -$43.70M | -337.9% |
| 2023 | $18.38M | +104.5% |
| 2022 | -$407.69M | -24.2% |
| 2021 | -$328.32M | -66.9% |
| 2020 | -$196.67M | -34.3% |
| 2019 | -$146.39M | -58.0% |
| 2018 | -$92.64M | -73.4% |
| 2017 | -$53.42M | -14.4% |
| 2016 | -$46.70M | -377.9% |
| 2015 | -$9.77M | +46.5% |
| 2014 | -$18.26M | — |
- HUTCHMED (China) Ltd showed an increase of +10.4% in Operating Income compared to the prior fiscal year.
- Over the 2014–2025 period, HUTCHMED (China) Ltd’s operating income has declined by 114.5% (from -$18.26 million to -$39.16 million).
- The most recent figure is from HUTCHMED (China) Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: